ESC Premium Access

Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Congress Presentation

About the speaker

Professor Eric Durand

University Hospital of Rouen, Rouen (France)
1 presentation
0 follower

4 more presentations in this session

State of the Art: TAVI indications and adoption: a dynamic field

Speaker: Professor B. Prendergast (London, GB)


Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Speaker: Doctor U. Fischer-Rasokat (Bad Nauheim, DE)


Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Speaker: Doctor B. Alushi (Albstadt, DE)


TAVI complications: incidence, trends and management.

Speaker: Doctor A. Chieffo (Milan, IT)


Access the full session

TAVI: a new standard for aortic valve replacement?

Speakers: Professor E. Durand, Professor B. Prendergast, Doctor U. Fischer-Rasokat, Doctor B. Alushi, Doctor A. Chieffo

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk